Ketao Jin

3.8k total citations
126 papers, 2.6k citations indexed

About

Ketao Jin is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ketao Jin has authored 126 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 49 papers in Molecular Biology and 32 papers in Cancer Research. Recurrent topics in Ketao Jin's work include Colorectal Cancer Treatments and Studies (16 papers), Cancer Research and Treatments (14 papers) and Cancer Cells and Metastasis (14 papers). Ketao Jin is often cited by papers focused on Colorectal Cancer Treatments and Studies (16 papers), Cancer Research and Treatments (14 papers) and Cancer Cells and Metastasis (14 papers). Ketao Jin collaborates with scholars based in China, United States and Canada. Ketao Jin's co-authors include Huanrong Lan, Lisong Teng, Kuifeng He, Xiaozhou Mou, Guangliang Li, Yong Han, Renzhong Liu, Jing Du, Xiqun Zhu and Zhenzhen Xu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Ketao Jin

124 papers receiving 2.6k citations

Peers

Ketao Jin

ONCOL

IMMUN

Nasser Hashemi Goradel Iran

Emilia Wiecheć Sweden

Liantao Li China

Hu Chen China

Matteo Parri Italy

Cindy H. Chau United States

Rasoul Salehi Iran

Karel Souček Czechia

Shengli Yang China

Nasser Hashemi Goradel Iran

Ketao Jin

1.2k ×1.1

744 ×0.9

ONCOL

450 ×0.8

293 ×0.9

571 ×1.9

IMMUN

Citations per year, relative to Ketao Jin Ketao Jin (= 1×) peers Nasser Hashemi Goradel

Countries citing papers authored by Ketao Jin

Since Specialization

Citations

This map shows the geographic impact of Ketao Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ketao Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ketao Jin more than expected).

Fields of papers citing papers by Ketao Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ketao Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ketao Jin. The network helps show where Ketao Jin may publish in the future.

Co-authorship network of co-authors of Ketao Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Ketao Jin. A scholar is included among the top collaborators of Ketao Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ketao Jin. Ketao Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yishu, Shao Su, Yuanhao Zhou, et al.. (2025). Oral administration of Folium Artemisiae Argyi-derived exosome-like nanovesicles can improve ulcerative colitis by regulating intestinal microorganisms. Phytomedicine. 137. 156376–156376. 15 indexed citations

He, Yichen, Xue Yang, Tong Ge, et al.. (2024). A novel acceptor–donor–acceptor structured molecule-based nanosystem for tumor mild photothermal therapy. Journal of Colloid and Interface Science. 670. 762–773. 5 indexed citations

Jin, Ketao, et al.. (2024). Exosomes in cancer diagnosis based on the Latest Evidence: Where are We?. International Immunopharmacology. 142(Pt A). 113133–113133. 2 indexed citations

Zheng, Wenjie, Jingxing Si, Xue Yang, et al.. (2024). Tumor-targeted delivery of copper-manganese biomineralized oncolytic adenovirus for colorectal cancer immunotherapy. Acta Biomaterialia. 179. 243–255. 10 indexed citations

Wang, Shibing, Xue Yang, Ketao Jin, et al.. (2024). An Engineered Self-biomineralized Oncolytic Adenovirus Induces Effective Antitumor Immunity and Synergizes With Immune Checkpoint Blockade. Cancer Immunology Research. 12(11). 1640–1654. 2 indexed citations

Yu, Guangmao, et al.. (2024). Advancing non-small cell lung cancer treatment: the power of combination immunotherapies. Frontiers in Immunology. 15. 1349502–1349502. 7 indexed citations

Ding, Kefeng, Qian Xiao, Jianbin Xiang, et al.. (2024). A randomized controlled trial of CAPEOX vs observation in patients with early-stage colorectal cancer with positive MRD after curative surgery (CAREME).. Journal of Clinical Oncology. 42(3_suppl). TPS225–TPS225. 1 indexed citations

Zhang, Zhongheng, Lin Chen, Haoyang Zhang, et al.. (2024). Genetic correlations and causal relationships between cardio-metabolic traits and sepsis. Scientific Reports. 14(1). 5718–5718. 3 indexed citations

Yu, Xiongfei, Yiran Chen, Jun Lü, et al.. (2022). Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study. Frontiers in Oncology. 12. 985154–985154. 6 indexed citations

10.

Lan, Huanrong, et al.. (2021). A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin‐Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti‐Inflammatory Activities. Oxidative Medicine and Cellular Longevity. 2021(1). 2951697–2951697. 38 indexed citations

11.

Lan, Huanrong, et al.. (2021). Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?. Frontiers in Oncology. 11. 769305–769305. 22 indexed citations

12.

Yang, Xue, et al.. (2021). Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold. Experimental Cell Research. 408(2). 112858–112858. 12 indexed citations

13.

Jin, Ketao, et al.. (2020). Nanomedicine and Early Cancer Diagnosis: Molecular Imaging using Fluorescence Nanoparticles. Current Topics in Medicinal Chemistry. 20(30). 2737–2761. 17 indexed citations

14.

Lian, Jiayan, Haibo Zhang, Fangqiang Wei, et al.. (2019). Long non-coding RNA DANCR promotes colorectal tumor growth by binding to lysine acetyltransferase 6A. Cellular Signalling. 67. 109502–109502. 23 indexed citations

15.

Shen, Yanping, Fang Zhang, Huanrong Lan, et al.. (2015). FRZB up-regulation is correlated with hepatic metastasis and poor prognosis in colon carcinoma patients with hepatic metastasis.. PubMed. 8(4). 4083–90. 7 indexed citations

16.

Huang, Jia, et al.. (2015). FRZB up-regulated in hepatocellular carcinoma bone metastasis.. PubMed. 8(10). 13353–9. 7 indexed citations

17.

Jin, Ketao, et al.. (2011). Vascular Endothelial Growth Factor in Breast Cancer: A Systematic Review. 8(3). 175–180. 1 indexed citations

18.

Jin, Ketao, Kuifeng He, Fei Teng, et al.. (2011). FP3: a novel VEGF blocker with antiangiogenic effects in vitro and antitumour effects in vivo. Clinical & Translational Oncology. 13(12). 878–884. 10 indexed citations

19.

Teng, Lisong, et al.. (2010). Advances in Combination of Antiangiogenic Agents Targeting VEGF-binding and Conventional Chemotherapy and Radiation for Cancer Treatment. Journal of the Chinese Medical Association. 73(6). 281–288. 22 indexed citations

20.

Jin, Ketao, et al.. (2004). Alzheimer病トランスジェニック(PDGF‐APPSw,Ind)マウス. Proc Natl Acad Sci USA. 101(36). 13363–13367. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact